Pfizer to Pull Back on Early-Stage Rare Disease Research, Selling Some Major Assets
Pfizer to Pull Back on Early-Stage Rare Disease Research, Selling Some Major Assets
辉瑞将撤回早期罕见病研究,出售部分主要资产
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册